Study of MRI-based biomarkers on patients with cerebral amyloid angiopathy using artificial intelligence

Cerebral Amyloid Angiopathy (CAA) is a neurodegenerative disease characterised by the deposition of the amyloid-beta (A β ) protein within the cortical and leptomeningeal blood vessels and capillaries. CAA leads to cognitive impairment, dementia, stroke, and a high risk of intracerebral haemorrhages...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva, Fátima Solange (author)
Outros Autores: Oliveira, Tiago Gil (author), Alves, Victor (author)
Formato: conferencePaper
Idioma:eng
Publicado em: 2021
Assuntos:
Artificial intelligence
Biomarkers
Cerebral Amyloid Angiopathy
Machine learning
Medical imaging
MRI
Texto completo:https://hdl.handle.net/1822/78115
País:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/78115

Texto Completo

https://hdl.handle.net/1822/78115

Registos relacionados